Applied Therapeutics, Inc.Applied Therapeutics, Inc.Applied Therapeutics, Inc.

Applied Therapeutics, Inc.

No trades
See on Supercharts
Market capitalization
‪541.51 M‬USD
−1.32USD
‪−119.76 M‬USD
‪9.99 M‬USD
‪89.33 M‬
Beta (1Y)
−1.45

About Applied Therapeutics, Inc.

CEO
Shoshana Shendelman
Headquarters
New York
Employees (FY)
25
Founded
2016
ISIN
US03828A1016
FIGI
BBG000DD0489
Applied Therapeutics, Inc. is a clinical-stage biopharmaceutical company which engages in the development of a pipeline of novel products. It is targeting treatments for central nervous system rare diseases and diabetic complications. The company was founded by Shoshana Shendelman on January 20, 2016 and is headquartered in New York, NY.
Performance
Revenue to profit conversion
Debt level and coverage
Earnings
Next:
‪0.00‬

See all ideas 

Summarizing what the indicators are suggesting.
Neutral
SellBuy
Strong sellStrong buy
Strong sellSellNeutralBuyStrong buy
Neutral
SellBuy
Strong sellStrong buy
Strong sellSellNeutralBuyStrong buy
Neutral
SellBuy
Strong sellStrong buy
Strong sellSellNeutralBuyStrong buy
An aggregate view of professional's ratings.
Neutral
SellBuy
Strong sellStrong buy
Strong sellSellNeutralBuyStrong buy
Neutral
SellBuy
Strong sellStrong buy
Strong sellSellNeutralBuyStrong buy
Neutral
SellBuy
Strong sellStrong buy
Strong sellSellNeutralBuyStrong buy
Trade directly on the supercharts through our supported, fully-verified and user-reviewed brokers.

Frequently Asked Questions

The current price of APLT is 4.66 USD — it has decreased by 1.79% in the past 24 hours.
Depending on the exchange, the stock ticker may vary. For instance, on NASDAQ exchange Applied Therapeutics, Inc. stocks are traded under the ticker APLT.
Applied Therapeutics, Inc. is going to release the next earnings report on May 9, 2024. Keep track of upcoming events with our Earnings Calendar.
APLT stock is 5.59% volatile and has beta coefficient of −1.45. Check out the list of the most volatile stocks — is Applied Therapeutics, Inc. there?
One year price forecast for Applied Therapeutics, Inc. has a max estimate of 14.00 USD and a min estimate of 7.00 USD.
APLT earnings for the last quarter are −0.47 USD per share, whereas the estimation was −0.24 USD resulting in a −92.39% surprise. The estimated earnings for the next quarter are −0.19 USD per share. See more details about Applied Therapeutics, Inc. earnings.
Applied Therapeutics, Inc. revenue for the last quarter amounts to ‪10.66 M‬ USD despite the estimated figure of ‪20.00 M‬ USD. In the next quarter revenue is expected to reach ‪8.00 M‬ USD.
Yes, you can track Applied Therapeutics, Inc. financials in yearly and quarterly reports right on TradingView.
APLT stock has fallen by 12.50% compared to the previous week, the month change is a 25.04% fall, over the last year Applied Therapeutics, Inc. has showed a 379.90% increase.
APLT net income for the last quarter is ‪−42.37 M‬ USD, while the quarter before that showed ‪−29.58 M‬ USD of net income which accounts for −43.25% change. Track more Applied Therapeutics, Inc. financial stats to get the full picture.
Today Applied Therapeutics, Inc. has the market capitalization of ‪541.51 M‬, it has decreased by 11.15% over the last week.
No, APLT doesn't pay any dividends to its shareholders. But don't worry, we've prepared a list of high-dividend stocks for you.
Like other stocks, APLT shares are traded on stock exchanges, e.g. Nasdaq, Nyse, Euronext, and the easiest way to buy them is through an online stock broker. To do this, you need to open an account and follow a broker's procedures, then start trading. You can trade Applied Therapeutics, Inc. stock right from TradingView charts — choose your broker and connect to your account.
APLT reached its all-time high on Feb 4, 2020 with the price of 57.39 USD, and its all-time low was 0.50 USD and was reached on Oct 12, 2022.
See other stocks reaching their highest and lowest prices.
As of Apr 19, 2024, the company has 25.00 employees. See our rating of the largest employees — is Applied Therapeutics, Inc. on this list?
Investing in stocks requires a comprehensive research: you should carefully study all the available data, e.g. company's financials, related news, and its technical analysis. So Applied Therapeutics, Inc. technincal analysis shows the sell today, and its 1 week rating is neutral. Since market conditions are prone to changes, it's worth looking a bit further into the future — according to the 1 month rating Applied Therapeutics, Inc. stock shows the neutral signal. See more of Applied Therapeutics, Inc. technicals for a more comprehensive analysis.
If you're still not sure, try looking for inspiration in our curated watchlists.
We've gathered analysts' opinions on Applied Therapeutics, Inc. future price: according to them, APLT price has a max estimate of 14.00 USD and a min estimate of 7.00 USD. Read a more detailed Applied Therapeutics, Inc. forecast: see what analysts think of Applied Therapeutics, Inc. and suggest that you do with its stocks.
EBITDA measures a company's operating performance, its growth signifies an improvement in the efficiency of a company. Applied Therapeutics, Inc. EBITDA is ‪−62.04 M‬ USD, and current EBITDA margin is −642.27%. See more stats in Applied Therapeutics, Inc. financial statements.